首页> 外文OA文献 >miRNA-binding site polymorphism in the 3UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab

【2h】

miRNA-binding site polymorphism in the 3UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab

机译：3UTR中的miRNA结合位点多态性； 5-氟尿嘧啶和奥沙利铂+/-西妥昔单抗治疗转移性结直肠癌患者的结直肠癌筛查人群患病率及其对临床结局的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Let-7 miRNA-binding site polymorphism in the KRAS 3 ′ UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/? cetuximab [J] . Janne B Kjersem, Tone Ikdahl, Tormod Guren, BMC Cancer . 2012,第1期

机译：KRAS 3'UTR中的let-7 miRNA结合位点多态性; 5-氟尿嘧啶和奥沙利铂+ /？治疗转移性结直肠癌患者的结直肠癌筛查人群患病率及其对临床结局的影响西妥昔单抗
2. FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab [J] . Janne B Kjersem, Eva Skovlund, Tone Ikdahl, BMC Cancer . 2014,第1期

机译：一线5-氟尿嘧啶/亚叶酸和奥沙利铂+/-西妥昔单抗治疗转移性结直肠癌患者的FCGR2A和FCGR3A基因多态性及临床结局
3. Transcription factor-binding sites in the thymidylate synthase gene: predictors of outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin? [J] . Pare L, Marcuello E, Altes A, The pharmacogenomics journal . 2008,第5期

机译：胸苷酸合酶基因中的转录因子结合位点：用5-氟尿嘧啶和奥沙利铂治疗转移性结直肠癌患者预后的指标？
4. PIK3CA Pathway and CTNNB1 Determine Poor Response of Cetuximab in Right-Sided Metastatic Colorectal Cancer [C] . Pi-Yueh Chang International Molecular Medicine Tri-Conference. . 2019

机译：Pik3CA途径和CTNNB1确定右侧转移性结肠直肠癌中西妥昔单抗的良差
5. Evaluation of the accuracy of quantitative models in predicting Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) mutations in a population-based sample of early-onset colorectal cancer patients [D] . Carpiniello, Lauren 2007

机译：在以人群为基础的早发性大肠癌患者样本中预测定量模型预测Lynch综合征（遗传性非息肉病性大肠直肠癌，DNA失配修复缺陷）的准确性
6. Let-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab [O] . Janne B Kjersem, Tone Ikdahl, Tormod Guren, 2012

机译：KRAS 3UTR中Let-7的miRNA结合位点多态性； 5-氟尿嘧啶和奥沙利铂+/-西妥昔单抗治疗转移性结直肠癌患者的结直肠癌筛查人群患病率及其对临床结局的影响
7. Let-7 miRNA-binding site polymorphism in the KRAS 3`UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab. [O] . Kjersem, Janne B, Ikdahl, Tone, Guren, Tormod, 2012

机译：KRAS 3`UTR中的let-7 miRNA结合位点多态性；用5-氟尿嘧啶和奥沙利铂+/-西妥昔单抗治疗转移性结直肠癌患者的结直肠癌筛查人群患病率及其对临床结局的影响。

miRNA-binding site polymorphism in the 3UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab

著录项

引文网络

相似文献

相关主题

期刊订阅